Upgrade to SI Premium - Free Trial

ACHFF (ACHFF)

0.65 +0.03 (4.84%)

Chart
Today 6M 1Y 5Y

Latest Headlines

Arch Biopartners to Expand Phase II Cardiac Surgery-Associated Acute Kidney Injury Trial to the United States August 11, 2026 7:44 AM - Globe NewsWire Arch Biopartners Engages Private Laboratory to Accelerate IL-32 Chronic Kidney Disease Program July 17, 2026 8:20 AM - Globe NewsWire Full Article List